Molecular Cytogenetic Characterization of the DiGeorge Syndrome Region Using Fluorescence in Situ Hybridization

Elizabeth A. Lindsay, Stephanie Halford, Roy Wadey, Peter J. Scambler, Antonio Baldini

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

DiGeorge syndrome (DGS) is a developmental defect characterized by cardiac defects, facial dysmorphism, and mental retardation. Several studies have described a critical region for DGS at 22q11, within which the majority of DGS patients have deletions. We have isolated nine cosmid and three YAC clones using previously described and newly isolated probes that have been shown to be deleted in many DGS patients. Using fluorescence in situ hybridization and digital imaging, we have mapped and ordered these clones relative to the breakpoints of two balanced translocations at 22q11 (one in a DGS patient and one in the unaffected parent of a DGS child). Our data indicate that the breakpoint in the unaffected individual distally limits the DGS critical region (defined as the smallest region of overlap), while proximally the region is limited by repeat-rich DNA. The critical region includes the balanced translocation breakpoint of the DGS patient that presumably disrupts the gene causing this syndrome.

Original languageEnglish
Pages (from-to)403-407
Number of pages5
JournalGenomics
Volume17
Issue number2
DOIs
Publication statusPublished - Aug 1993

Fingerprint

DiGeorge Syndrome
Fluorescence In Situ Hybridization
Cytogenetics
Clone Cells
Cosmids
Intellectual Disability
DNA

ASJC Scopus subject areas

  • Genetics

Cite this

Molecular Cytogenetic Characterization of the DiGeorge Syndrome Region Using Fluorescence in Situ Hybridization. / Lindsay, Elizabeth A.; Halford, Stephanie; Wadey, Roy; Scambler, Peter J.; Baldini, Antonio.

In: Genomics, Vol. 17, No. 2, 08.1993, p. 403-407.

Research output: Contribution to journalArticle

Lindsay, Elizabeth A. ; Halford, Stephanie ; Wadey, Roy ; Scambler, Peter J. ; Baldini, Antonio. / Molecular Cytogenetic Characterization of the DiGeorge Syndrome Region Using Fluorescence in Situ Hybridization. In: Genomics. 1993 ; Vol. 17, No. 2. pp. 403-407.
@article{8810ee1bcf78408182a077200465e44c,
title = "Molecular Cytogenetic Characterization of the DiGeorge Syndrome Region Using Fluorescence in Situ Hybridization",
abstract = "DiGeorge syndrome (DGS) is a developmental defect characterized by cardiac defects, facial dysmorphism, and mental retardation. Several studies have described a critical region for DGS at 22q11, within which the majority of DGS patients have deletions. We have isolated nine cosmid and three YAC clones using previously described and newly isolated probes that have been shown to be deleted in many DGS patients. Using fluorescence in situ hybridization and digital imaging, we have mapped and ordered these clones relative to the breakpoints of two balanced translocations at 22q11 (one in a DGS patient and one in the unaffected parent of a DGS child). Our data indicate that the breakpoint in the unaffected individual distally limits the DGS critical region (defined as the smallest region of overlap), while proximally the region is limited by repeat-rich DNA. The critical region includes the balanced translocation breakpoint of the DGS patient that presumably disrupts the gene causing this syndrome.",
author = "Lindsay, {Elizabeth A.} and Stephanie Halford and Roy Wadey and Scambler, {Peter J.} and Antonio Baldini",
year = "1993",
month = "8",
doi = "10.1006/geno.1993.1339",
language = "English",
volume = "17",
pages = "403--407",
journal = "Genomics",
issn = "0888-7543",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Molecular Cytogenetic Characterization of the DiGeorge Syndrome Region Using Fluorescence in Situ Hybridization

AU - Lindsay, Elizabeth A.

AU - Halford, Stephanie

AU - Wadey, Roy

AU - Scambler, Peter J.

AU - Baldini, Antonio

PY - 1993/8

Y1 - 1993/8

N2 - DiGeorge syndrome (DGS) is a developmental defect characterized by cardiac defects, facial dysmorphism, and mental retardation. Several studies have described a critical region for DGS at 22q11, within which the majority of DGS patients have deletions. We have isolated nine cosmid and three YAC clones using previously described and newly isolated probes that have been shown to be deleted in many DGS patients. Using fluorescence in situ hybridization and digital imaging, we have mapped and ordered these clones relative to the breakpoints of two balanced translocations at 22q11 (one in a DGS patient and one in the unaffected parent of a DGS child). Our data indicate that the breakpoint in the unaffected individual distally limits the DGS critical region (defined as the smallest region of overlap), while proximally the region is limited by repeat-rich DNA. The critical region includes the balanced translocation breakpoint of the DGS patient that presumably disrupts the gene causing this syndrome.

AB - DiGeorge syndrome (DGS) is a developmental defect characterized by cardiac defects, facial dysmorphism, and mental retardation. Several studies have described a critical region for DGS at 22q11, within which the majority of DGS patients have deletions. We have isolated nine cosmid and three YAC clones using previously described and newly isolated probes that have been shown to be deleted in many DGS patients. Using fluorescence in situ hybridization and digital imaging, we have mapped and ordered these clones relative to the breakpoints of two balanced translocations at 22q11 (one in a DGS patient and one in the unaffected parent of a DGS child). Our data indicate that the breakpoint in the unaffected individual distally limits the DGS critical region (defined as the smallest region of overlap), while proximally the region is limited by repeat-rich DNA. The critical region includes the balanced translocation breakpoint of the DGS patient that presumably disrupts the gene causing this syndrome.

UR - http://www.scopus.com/inward/record.url?scp=0027328673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027328673&partnerID=8YFLogxK

U2 - 10.1006/geno.1993.1339

DO - 10.1006/geno.1993.1339

M3 - Article

C2 - 8406492

AN - SCOPUS:0027328673

VL - 17

SP - 403

EP - 407

JO - Genomics

JF - Genomics

SN - 0888-7543

IS - 2

ER -